283
Views
9
CrossRef citations to date
0
Altmetric
Review

Betaine Supplementation Moderately Increases Total Cholesterol Levels: A Systematic Review and Meta-Analysis

, MScORCID Icon, , PhDORCID Icon & , PhDORCID Icon

References

  • Abdelmalek MF, Angulo P, Jorgensen R, Sylvestre PB, Lindor KD. 2001. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am J Gastroenterol. 96(9):2711–2717. doi:10.1111/j.1572-0241.2001.04129.x.
  • Atkinson W, Slow S, Elmslie J, Lever M, Chambers ST, George PM. 2009. Dietary and supplementary betaine: Effects on betaine and homocysteine concentrations in males. Nutr Metab Cardiovasc Dis. 19(11):767–773. doi:10.1016/j.numecd.2009.01.004.
  • Cholewa JM, Guimarães-Ferreira L, Zanchi NE. 2014. Effects of betaine on performance and body composition: a review of recent findings and potential mechanisms. Amino Acids. 46(8):1785–1789. doi:10.1007/s00726-014-1748-5.
  • Cohen J. 1988. Statistical power analysis for the behavioral sciences. New York (NY): Lawrence Erlbaum Associates.
  • Craig SA. 2004. Betaine in human nutrition. Am J Clin Nutr. 80(3):539–549. doi:10.1093/ajcn/80.3.539.
  • Day CR, Kempson SA. 2016. Betaine chemistry, roles, and potential use in liver disease. Biochim Biophys Acta Gen Subj. 1860(6):1098–1106. doi:10.1016/j.bbagen.2016.02.001.
  • Egger M, Smith GD, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ. 315(7109):629–634. doi:10.1136/bmj.315.7109.629.
  • Grizales AM, Patti M-E, Lin AP, Beckman JA, Sahni VA, Cloutier E, Fowler KM, Dreyfuss JM, Pan H, Kozuka C, et al. 2018. Metabolic effects of betaine: a randomized clinical trial of betaine supplementation in prediabetes. J Clin Endocrinol Metab. 103(8):3038–3049. doi:10.1210/jc.2018-00507.
  • Higgins JPT, Green S. 2011. Cochrane handbook for systematic reviews of interventions Version 5.1.0. The Cochrane Collaboration. Hoboken (NJ): John Wiley & Sons.
  • Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JPA, Straus A, Thorlund K, Jansen JP, et al. 2015. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 162(11):777–784. doi:10.7326/M14-2385.
  • Jeong S-M, Choi S, Kim K, Kim SM, Lee G, Park SJ, Kim YY, Son JS, Yun JM, Park SM. 2018. Effect of change in total cholesterol levels on cardiovascular disease among young adults. J Am Heart Assoc. 7(12):e008819 doi:10.1161/JAHA.118.008819.
  • Kharbanda KK, Mailliard ME, Baldwin CR, Beckenhauer HC, Sorrell MF, Tuma DJ. 2007. Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway. J Hepatol. 46(2):314–321. doi:10.1016/j.jhep.2006.08.024.
  • Kharbanda KK, Todero SL, Ward BW, Cannella JJ, Tuma DJ. 2009. Betaine administration corrects ethanol-induced defective VLDL secretion. Mol Cell Biochem. 327(1-2):75–78. doi:10.1007/s11010-009-0044-2.
  • Kumar T, Sharma GS, Singh LR. 2016. Homocystinuria: therapeutic approach. Clin Chim Acta. 458:55–62. doi:10.1016/j.cca.2016.04.002.
  • Lever M, George PM, Atkinson W, Molyneux SL, Elmslie JL, Slow S, Richards AM, Chambers ST. 2011. Plasma lipids and betaine are related in an acute coronary syndrome cohort. PLoS One. 6(7):e21666. doi:10.1371/journal.pone.0021666.
  • Malinowska A, Chmurzynska A. 2009. Polymorphism of genes encoding homocysteine metabolism–related enzymes and risk for cardiovascular disease. Nutr Res. 29(10):685–695. doi:10.1016/j.nutres.2009.09.018.
  • Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M. 2017. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 8:CD006612. doi:10.1002/14651858.CD006612.pub5.
  • McRae MP. 2013. Betaine supplementation decreases plasma homocysteine in healthy adult participants: a meta-analysis. J Chiropr Med. 12(1):20–25. doi:10.1016/j.jcm.2012.11.001.
  • Nagasawa S-Y, Okamura T, Iso H, et al. 2012 Relation between serum total cholesterol level and cardiovascular disease stratified by sex and age group: a pooled analysis of 65 594 individuals from 10 cohort studies in Japan. J Am Heart Assoc. 7:e008819. doi:10.1161/JAHA.112.001974.
  • Normand ST. 1999. Meta-analysis: Formulating, evaluating, combining, and reporting. Statist Med. 18(3):321–359. doi:10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P.
  • Olthof MR, van Vliet T, Boelsma E, Verhoef P. 2003. Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. J Nutr. 133(12):4135–4138. doi:10.1093/jn/133.12.4135.
  • Olthof MR, Van Vliet T, Verhoef P, Zock PL, Katan MB. 2005. Effect of homocysteine-lowering nutrients on blood lipids: Results from four randomised, placebo-controlled studies in healthy humans. PLoS Med. 2(5):e135–0456. doi:10.1371/journal.pmed.0020135.
  • Price RK, Keaveney EM, Hamill LL, Wallace JM, Ward M, Ueland PM, McNulty H, Strain JJ, Parker MJ, Welch RW. 2010. Consumption of wheat aleurone-rich foods increases fasting plasma betaine and modestly decreases fasting homocysteine and LDL-cholesterol in adults. J Nutr. 140(12):2153–2157. doi:10.3945/jn.110.126961.
  • Schwab U, Alfthan G, Aro A, Uusitupa M. 2011. Long-term effect of betaine on risk factors associated with the metabolic syndrome in healthy subjects. Eur J Clin Nutr. 65(1):70–76. doi:10.1038/ejcn.2010.230.
  • Schwab U, Törrönen A, Toppinen L, Alfthan G, Saarinen M, Aro A, Uusitupa M. 2002. Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. Am J Clin Nutr. 76(5):961–967. doi:10.1093/ajcn/76.5.961.
  • Škovierová H, Vidomanová E, Mahmood S, Sopková J, Drgová A, Červeňová T, Halašová E, Lehotský J. 2016. The molecular and cellular effect of homocysteine metabolism imbalance on human health. Int J Mol Sci. 17(10): 1733. pii: E1733 doi:10.3390/ijms17101733.
  • Sparks JD, Collins HL, Chirieac DV, Cianci J, Jokinen J, Sowden MP, Galloway CA, Sparks CE. 2006. Hepatic very-low-density lipoprotein and apolipoprotein B production are increased following in vivo induction of betaine-homocysteine S-methyltransferase. Biochem J. 395(2):363–371. doi:10.1042/BJ20051966.
  • Steenge GR, Verhoef P, Katan MB. 2003. Betaine supplementation lowers plasma homocysteine in healthy men and women. J Nutr. 133(5):1291–1295. doi:10.1093/jn/133.5.1291.
  • Viechtbauer W. 2010. Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1–48. doi:10.18637/jss.v036.i03.
  • Wang LJ, Zhang HW, Zhou JY, Liu Y, Yang Y, Chen XL, Zhu CH, Zheng RD, Ling WH, Zhu HL. 2014. Betaine attenuates hepatic steatosis by reducing methylation of the MTTP promoter and elevating genomic methylation in mice fed a high-fat diet. J Nutr Biochem. 25(3):329–336. doi:10.1016/j.jnutbio.2013.11.007.
  • Yao ZM, Vance DE. 1989. Head group specificity in the requirement of phosphatidylcholine biosynthesis for very low density lipoprotein secretion from cultured hepatocytes. J Biol Chem. 264(19):11373–11380. http://www.ncbi.nlm.nih.gov/pubmed/2738069. Accessed February 1, 2019.
  • Zeisel SH, Mar M-H, Howe JC, Holden JM. 2003. Concentrations of choline-containing compounds and betaine in common foods. J Nutr. 133(5):1302–1307. doi:10.1093/jn/133.5.1302.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.